Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
TRIHEXYPHENIDYL TREATMENT OF CLOZAPINE-INDUCED HYPERSALIVATION
Autore:
SPIVAK B; ADLERSBERG S; ROSEN L; GONEN N; MESTER R; WEIZMAN A;
Indirizzi:
NESS ZIONA MENTAL HLTH CTR,POB 1 IL-74100 NESS ZIONA ISRAEL TEL AVIV UNIV,SACKLER FAC MED IL-69978 TEL AVIV ISRAEL BEILINSON MED CTR,GEHA PSYCHIAT HOSP IL-49100 PETAH TIQWA ISRAEL RABIN MED CTR,FELSENSTEIN MED RES CTR PETAH TIQWA ISRAEL
Titolo Testata:
International clinical psychopharmacology
fascicolo: 4, volume: 12, anno: 1997,
pagine: 213 - 215
SICI:
0268-1315(1997)12:4<213:TTOCH>2.0.ZU;2-8
Fonte:
ISI
Lingua:
ENG
Soggetto:
ANTAGONISTS; RECEPTORS;
Keywords:
CLOZAPINE; HYPERSALIVATION; TRIHEXYPHENIDYL;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
13
Recensione:
Indirizzi per estratti:
Citazione:
B. Spivak et al., "TRIHEXYPHENIDYL TREATMENT OF CLOZAPINE-INDUCED HYPERSALIVATION", International clinical psychopharmacology, 12(4), 1997, pp. 213-215

Abstract

The objective of this study was to investigate the efficacy of the anticholinergic agent trihexyphenidyl in the treatment of clozapine-induced hypersalivation. Fourteen chronic schizophrenic patients who exhibited nocturnal hypersalivation during clozapine treatment were coadministered trihexyphenidyl (5-15 mg/day, at bedtime) for 15 days. Salivation was assessed by a single-item 5-point scale. A reduction of 44% inthe reported nocturnal hypersalivation was observed after trihexyphenidyl treatment. These results indicate that at least some chronic schizophrenic patients with clozapine-induced nocturnal hypersalivation may benefit from anticholinergic treatment.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/03/20 alle ore 22:46:36